Related Experiment Videos
CD6-ligand interactions: a paradigm for SRCR domain function?
A Aruffo1, M A Bowen, D D Patel
1Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121, USA. aruffo@bms.com
Insights
The scavenger receptor cysteine-rich (SRCR) superfamily includes CD6, a lymphocyte receptor. This review details the CD6-ALCAM interaction, offering insights into SRCR domain ligand binding mechanisms.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- The scavenger receptor cysteine-rich (SRCR) superfamily comprises proteins involved in cellular processes.
- Leukocyte-expressed SRCR proteins are classified into groups A and B.
- Group B includes CD6, a key lymphocyte cell-surface receptor.
Purpose of the Study:
- To review recent advancements in understanding the CD6-ALCAM interaction.
- To explore the significance of CD6-ALCAM binding in cellular communication.
- To provide insights into broader SRCR domain-ligand binding mechanisms.
Main Methods:
- Literature review of recent research on CD6 and ALCAM.
- Analysis of molecular interactions between CD6 and ALCAM.
- Comparative analysis of SRCR superfamily members and their ligands.
Main Results:
- Recent progress highlights the intricate nature of the CD6-ALCAM interaction.
- Understanding this interaction is crucial for deciphering leukocyte function.
- The CD6-ALCAM system serves as a model for other SRCR-ligand interactions.
Conclusions:
- The CD6-ALCAM interaction is a significant area of immunological research.
- Further analysis of CD6-ALCAM binding will illuminate SRCR superfamily functions.
- This review provides a foundation for future studies on SRCR-mediated cellular adhesion and signaling.
Abstract:
The scavenger receptor cysteine-rich (SRCR) superfamily, which includes proteins expressed by leukocytes, can be subdivided into groups A and B. Group B contains the lymphocyte cell-surface receptor CD6. This article reviews recent progress in understanding the interaction between CD6 and its ligand, activated leukocyte cell adhesion molecule (ALCAM). Analysis of the CD6-ALCAM interaction may help to understand how other SRCR domains bind to their ligands.